These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7690101)

  • 1. Effect of KRN2391 on venous return: comparison with other vasodilators.
    Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
    Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide.
    Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological analysis of the vasodepressor effect of KRN2391 in pithed rats.
    Tanaka Y; Yokoyama T; Kashiwabara T; Fukushima H; Izawa T; Ogawa N
    Gen Pharmacol; 1993 Nov; 24(6):1379-81. PubMed ID: 8112509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
    Imagawa J; Akima M; Nabata H; Taira N
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic profile of KRN2391, a novel vasodilator, in anesthetized dogs.
    Ogawa N; Jinno Y; Kaneta S; Harada K; Fukata Y; Fukushima H
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):874-82. PubMed ID: 7687711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the effect of KRN2391 on coronary vasculature in perfused rat heart.
    Miwa A; Jinno Y; Yokoyama T; Izawa T; Ogawa N
    Gen Pharmacol; 1994 May; 25(3):471-4. PubMed ID: 7926593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of KRN2391, nitroglycerin and cromakalim in dihydroergotamine-treated pithed rats.
    Kaneta S; Kashiwabara T; Tanaka Y; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):963-8. PubMed ID: 7835645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cardiovascular effects of KRN2391 and other coronary vasodilators in anesthetized open-chest dogs.
    Ogawa N; Kaneta S; Jinno Y; Kasai H; Nishikori K; Fukushima H
    Arch Int Pharmacodyn Ther; 1992; 318():36-46. PubMed ID: 1463370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
    Kamijo T; Iwai T; Haruta K; Takeda K
    Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
    Yoneyama F; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.
    Kamijo T; Kamei K; Sugo I; Kamiyama T; Sudo H; Ohba Y
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):93-101. PubMed ID: 9890402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation by KRN2391 and nicorandil of glibenclamide-sensitive K+ channels in Xenopus oocytes.
    Sakuta H; Okamoto K
    Eur J Pharmacol; 1993 Feb; 244(3):277-83. PubMed ID: 8458402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
    Hirata Y; Aisaka K
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.